Barbara Scepura
6PUBLICATIONS
74CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 05, 2025
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.Michael I Barbato, Amy K Barone, Stephanie L Aungst
|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.Sonia Singh, Diana Bradford, Somak Chatterjee
|Jun 14, 2024
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer.Michael I Barbato, Diana Bradford, Yi Ren
|Aug 23, 2023
FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation-Positive Low-Grade Glioma.Michael I Barbato, Jeannette Nashed, Diana Bradford
|Jun 02, 2023
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.Elizabeth S Duke, Diana Bradford, Michelle Marcovitz
|Sep 16, 2022
FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.Elizabeth S Duke, Liza Stapleford, Nicole Drezner
Pageof 1
Frequent Collaborators
6 joint publications
Richard Pazdur
6 joint publications
Youwei Bi
5 joint publications
Harpreet Singh
5 joint publications
Nicole Drezner
4 joint publications
Anup K Amatya
4 joint publications
Pallavi S Mishra-Kalyani
4 joint publications
Diana Bradford
4 joint publications
Jeanne Fourie Zirkelbach
4 joint publications
Claudia P Miller
3 joint publications
Martha Donoghue
